Ryo Hatano

8PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersMechanobiologyAutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 17, 2026
IL-26-driven epigenetic remodeling promotes immune evasion in colorectal cancer.

|Aug 14, 2025
Anti-CD26 Antibody Suppresses Epithelial-Mesenchymal Transition in Colorectal Cancer Stem Cells.

Takumi Iwasawa, Ryo Hatano, Satoshi Takeda

|Dec 17, 2024
Transcriptome Analysis of Fibroblasts in Hypoxia-Induced Vascular Remodeling: Functional Roles of CD26/DPP4.

Yuri Suzuki, Takeshi Kawasaki, Koichiro Tatsumi

|Oct 09, 2024
An abnormal increase in CD26(-)CD28(-) cytotoxic effector CD4 and CD8 T cell populations in patients with systemic lupus erythematosus.

Ryo Hatano, Hayato Nakamura, Ayako Yamamoto

|Jan 23, 2024
Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease.

Tadasu Okaya, Takeshi Kawasaki, Shun Sato

|Aug 26, 2023
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.

Eiji Kobayashi, Yusuke Kamihara, Miho Arai

Pageof 2

Frequent Collaborators

2 joint publications

Shohei Kikuchi

2 joint publications

Akinori Wada

2 joint publications

Yoshihiro Hayakawa

2 joint publications

Takeshi Kawasaki